MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org on October 6, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on October 6, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Laron dwarfism.
Laron dwarfism: growth and immunoreactive insulin following treatment with human growth hormone.
Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I.
The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism.
Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism.
Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).
Effect of insulin-like growth factor I on the thyroid axis in patients with Laron-type dwarfism and healthy subjects.
Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature.
IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.
Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation?
Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism.
Growth hormone receptor deficiency (Laron syndrome): clinical and genetic characteristics.
[Laron syndrome: Presentation, treatment and prognosis].
Reduced sweating in Laron's dwarfism.
Long-term effects of human growth hormone on plasma amino acids transport in hypopituitary dwarfism.
Deletion in the EVC2 gene causes chondrodysplastic dwarfism in Tyrolean Grey cattle.
Phytochrome-mediated synthesis of novel growth inhibitors, A-2α and β, and dwarfism in peas.
Primordial dwarfism: an update.
[Mesomelic dwarfism (author's transl)].
Familial dwarfism: case report.
Psychiatric aspects of dwarfism.
Neonatal death dwarfism.
Abnormalities of tooth development in pituitary dwarfism.
Growth hormone-receptor gene in Laron dwarfism.
The New England Journal of Medicine Downloaded from nejm.org on October 6, 2015. For personal use only. No other uses without permission. Copyright ©...
1MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Laron dwarfism.
Laron dwarfism: growth and immunoreactive insulin following treatment with human growth hormone.
Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I.
The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism.
Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism.
Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).
Effect of insulin-like growth factor I on the thyroid axis in patients with Laron-type dwarfism and healthy subjects.
Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature.
IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms